MedTrace Logo

The Effects of Dietary Palmitic Acid Triacylglyceride Position on Intestinal Parameters in Infants (InFat_005)

NCT01116115 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-05-17

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on intestinal parameters in term formula fed infants.

Conditions

  • Health Behavior
  • Disorder of Growth and Development

Interventions

OTHER

InFat™ based infant formula

High sn-2 palmitic acid oil based infant formula

OTHER

Standard vegetable oil based infant formula

Standard vegetable oil based infant formula

Sponsors & Collaborators

  • Enzymotec

    lead INDUSTRY

Principal Investigators

  • Arie Riskin, MD · Bnai Zion Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
7 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01116115 on ClinicalTrials.gov